J Investigative Med

Official journal of the AFMR, Publishing high-quality research from the biomedical community. @AFMResearch and #BMJ

[J Investigative Med @JIM_AFMR]

Our latest metrics including Impact Factor, CiteScore and days from acceptance to publication are here!

Click here to discover more > https://t.co/UELv1EtoBD #BMJImpact

[BMJ_Open @BMJ_Open]

Authors saved, on average, 40 days in receiving a decision on their article when they transferred to another BMJ journal in 2022 (compared to submitting elsewhere). Watch this video to find out how to process an editor-suggested transfer. https://t.co/lYElqdwlGC

[BMJ_Open @BMJ_Open]

Our article transfer service provides authors with a quick, easy and smooth submission and #peerreview service. Find out more about why you should use it: https://t.co/iTJjdc1K9n

[J Investigative Med @JIM_AFMR]

https://t.co/xZ8RGSifW7
Happy Thanksgiving. Please enjoy this latest episode of the JIM podcast as we explore the valleys and mountain tops of living with Cystic Fibrosis from a patient perspective. Life is what you make of it. @AFMResearch @JohnDDickinson1

[J Investigative Med @JIM_AFMR]

https://t.co/Fo0Z0aTH4D
@AFMResearch
New research published in JIM shows the treatment potential for novel Angiotensin II receptor blockers, allisartan, in a model of high fat diet induced inflammation.

[J Investigative Med @JIM_AFMR]

https://t.co/4Ic2PB4RoV
@AFMResearch
New perspectives from Dr. Baer https://t.co/NX3Gl73xBW the 1,000,000+ Renal reporting data base in the United States. Overall, the prevalence of NTM infection led to increased mortality by multivariable analysis in dialysis patients.

[J Investigative Med @JIM_AFMR]

https://t.co/AKcjK13lEP
Ying-Chou Chen and colleagues provide some interesting data from a cross sectional case control study of men with gout. Using data from DXA scans, both lean and fat mass were associated with development of gout.
@AFMResearch

[J Investigative Med @JIM_AFMR]

Current hemodialysis has been a lifesaving modality yet it has limitations. Newer technologies are needed to improve outcomes. In this concise review, Teressa and Jonny provide a glimpse at new dialysis technologies to improve outcomes. @AFMResearch
https://t.co/VrHZSzeOCI

[J Investigative Med @JIM_AFMR]

Check out our latest JIM podcast on the trials and progress in Sickle Cell Disease (SCD). Our guest this month is Dr. Greg Vercellotti from the University of Minnesota. Dr. Vercellotti is a physician scientist focused on SCD. @AFMResearch
https://t.co/ARUmWPpxFK

[J Investigative Med @JIM_AFMR]

https://t.co/QaoW77gEfR
New podcast up!
JIM's editor Dr. Richard McCallum provides a succinct and practical oversight in to the diagnosis and management of gastroparesis.
@AFMResearch

[J Investigative Med @JIM_AFMR]

https://t.co/ZZY2QP89gN
@AFMResearch
Please see this fascinating review published in JIM detailing new data on bacterial-human interactions through small coding RNAs.

[J Investigative Med @JIM_AFMR]

https://t.co/KXHvVZrnMI

A new study identifies the impact of the COVID-19 pandemic on utilization of gastroenterology services and the importance of social determinants of health.
@AFMResearch

[J Investigative Med @JIM_AFMR]

https://t.co/GORbml8fWY
This study hightlights a novel method for detecting dynamic thiol-disulfide oxidation which may lead to know insights in the disease pathogenesis of Chronic Lymphocytic Anemia.
@AFMResearch

[J Investigative Med @JIM_AFMR]

As the COVID pandemic continues to unfold, we discover the role of modifying medications. In this study by Fatma Dihowm et al, we see the protective role of statin medications in outcomes for COVID-19. Bottom line -do not stop statins. @AFMResearch
https://t.co/H8XzY1moNX

[J Investigative Med @JIM_AFMR]

https://t.co/zoabpC2Ozd

Curious about the NIH Loan Repayment Program (LRP) ? Check out this podcast from JIM where we interview Dr Sara Myers about LRP details and eligibility.
@AFMResearch

[J Investigative Med @JIM_AFMR]

Want to read our top-cited papers? We’ve made them free to read 📰👀
Read shortlisted papers here
> https://t.co/2kvcinYPaD 👈
#BMJImpact

[J Investigative Med @JIM_AFMR]

🚨To celebrate our research impact, we’ve made our most cited papers free to read 📰

Explore them here >https://t.co/2kvcinYPaD 👈
#BMJImpact

[J Investigative Med @JIM_AFMR]

Our latest metrics including Impact Factor, CiteScore and days from acceptance to publication are here! 📈

Click here to discover more
> https://t.co/2kvcinYPaD 👈
#BMJImpact

[J Investigative Med @JIM_AFMR]

https://t.co/WMK9J8O9nC

June 2022 issue of JIM

[J Investigative Med @JIM_AFMR]

https://t.co/XG2H1hfsgS
https://t.co/4ByMEetn7I

Here is a fantastic methods paper to help you strengthen your own clinical/translational study and better scrutinize the works of others that you critically reviewing.

@AFMResearch

[J Investigative Med @JIM_AFMR]

Thank you Samrat Das for your vision and leadership at AFRM.
https://t.co/v7BmctZd1k

Please join us in this JIM Podcast with Drs. McCallum and Das as they discuss where we are at AFMR and where we are going in the future. @AFMResearch @SamratD40417560